Stock NBIO NASCENT BIOTECH, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Nascent Biotech, Inc.

Equities

NBIO

US63108Q1013

Market Closed - OTC Markets
Other stock markets
 01:20:47 01/06/2024 am IST 		5-day change 1st Jan Change
0.099 USD +0.51% Intraday chart for Nascent Biotech, Inc. +1.43% -42.74%
16/04 Nascent Biotech, Inc. Prepares for Pivotal Phase II Research with Fresh Manufacturing Run CI
19/03 Nascent Collaborates With Hypospray Pharma Announces Collaboration to Develop an Alternative Delivery Mechanism for Patients Who Can Benefit from Pritumumab CI

Press Releases

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Nascent Prepares for Pivotal Phase II Research with Fresh Manufacturing Run
AQ
Nascent Biotech Receives an Analyst Opinion Suggesting that of the Company is significantly under Valued
AQ
Nascent Biotech Completes Payment of Variable Convertible Note in Full to Eliminate Dilution Risk
AQ
Nascent Biotech : Termination of Material Agreement - Form 8-K
PU
NASCENT BIOTECH INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
NASCENT BIOTECH INC. : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERTIONS (form 10-Q)
AQ
NASCENT BIOTECH INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
Nascent Enrolls Final Patient Cohort in Phase I Brain Cancer Trial
AQ
NASCENT BIOTECH INC. : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERTIONS (form 10-Q)
AQ
Nascent Biotech Receives Notice of the Issuance of US Patent No.11,494,394
AQ
NASCENT BIOTECH INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)
AQ
NASCENT BIOTECH INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)
AQ
NASCENT BIOTECH INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)
AQ
NASCENT BIOTECH INC. Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K/A)
AQ
NASCENT BIOTECH INC. Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K/A)
AQ
NASCENT BIOTECH INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)
AQ
NASCENT BIOTECH INC. : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERTIONS (form 10-Q)
AQ
Nascent Biotech : Receives Notice of Allowance from USPTO for Issuance of Additional Patent
PU
NASCENT BIOTECH INC. : MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION (form 10-K)
AQ
NASCENT BIOTECH INC. : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERTIONS (form 10-Q)
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NBIO Stock
  4. News Nascent Biotech, Inc.
  5. Press Releases